599 related articles for article (PubMed ID: 34093179)
1. Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders.
Navarrete F; García-Gutiérrez MS; Gasparyan A; Austrich-Olivares A; Manzanares J
Front Pharmacol; 2021; 12():626010. PubMed ID: 34093179
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol and substance use disorder: Dream or reality.
Karimi-Haghighi S; Razavi Y; Iezzi D; Scheyer AF; Manzoni O; Haghparast A
Neuropharmacology; 2022 Apr; 207():108948. PubMed ID: 35032495
[TBL] [Abstract][Full Text] [Related]
3. Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
Elsaid S; Kloiber S; Le Foll B
Prog Mol Biol Transl Sci; 2019; 167():25-75. PubMed ID: 31601406
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol in the context of substance use disorder treatment: A systematic review.
Paulus V; Billieux J; Benyamina A; Karila L
Addict Behav; 2022 Sep; 132():107360. PubMed ID: 35580370
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia.
Osborne AL; Solowij N; Weston-Green K
Neurosci Biobehav Rev; 2017 Jan; 72():310-324. PubMed ID: 27884751
[TBL] [Abstract][Full Text] [Related]
6. The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder.
Chye Y; Christensen E; Solowij N; Yücel M
Front Psychiatry; 2019; 10():63. PubMed ID: 30837904
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms.
Calpe-López C; García-Pardo MP; Aguilar MA
Molecules; 2019 Jul; 24(14):. PubMed ID: 31315244
[TBL] [Abstract][Full Text] [Related]
8. Use of cannabidiol (CBD) for the treatment of cognitive impairment in psychiatric and neurological illness: A narrative review.
Ortiz R; Rueda S; Di Ciano P
Exp Clin Psychopharmacol; 2023 Oct; 31(5):978-988. PubMed ID: 37126037
[TBL] [Abstract][Full Text] [Related]
9. Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease.
Silvestro S; Schepici G; Bramanti P; Mazzon E
Molecules; 2020 Nov; 25(21):. PubMed ID: 33171772
[TBL] [Abstract][Full Text] [Related]
10. Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review.
Singh K; Bhushan B; Chanchal DK; Sharma SK; Rani K; Yadav MK; Porwal P; Kumar S; Sharma A; Virmani T; Kumar G; Noman AA
Behav Neurol; 2023; 2023():8825358. PubMed ID: 37868743
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Effects of Cannabidiol on Methamphetamine Abuse: A Review of Preclinical Study.
Razavi Y; Keyhanfar F; Shabani R; Haghparast A; Mehdizadeh M
Iran J Pharm Res; 2021; 20(4):152-164. PubMed ID: 35194436
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action.
Ożarowski M; Karpiński TM; Zielińska A; Souto EB; Wielgus K
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919010
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Assessment of the Abuse Potential of Purified Botanical Cannabidiol: Self-Administration, Drug Discrimination, and Physical Dependence.
Gray RA; Heal DJ; Maguire DR; Gerak LR; Javors MA; Smith S; France CP
J Pharmacol Exp Ther; 2022 Jul; 382(1):54-65. PubMed ID: 35489780
[TBL] [Abstract][Full Text] [Related]
14. Neurological Aspects of Medical Use of Cannabidiol.
Mannucci C; Navarra M; Calapai F; Spagnolo EV; Busardò FP; Cas RD; Ippolito FM; Calapai G
CNS Neurol Disord Drug Targets; 2017; 16(5):541-553. PubMed ID: 28412918
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
Golub V; Reddy DS
Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
[TBL] [Abstract][Full Text] [Related]
16. Source of cannabinoids: what is available, what is used, and where does it come from?
Specchio N; Pietrafusa N; Cross HJ
Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
18. Current application of cannabidiol (CBD) in the management and treatment of neurological disorders.
Fiani B; Sarhadi KJ; Soula M; Zafar A; Quadri SA
Neurol Sci; 2020 Nov; 41(11):3085-3098. PubMed ID: 32556748
[TBL] [Abstract][Full Text] [Related]
19. Is Cannabidiol a Promising Substance for New Drug Development? A Review of its Potential Therapeutic Applications.
Noreen N; Muhammad F; Akhtar B; Azam F; Anwar MI
Crit Rev Eukaryot Gene Expr; 2018; 28(1):73-86. PubMed ID: 29773016
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Efficacy of Cannabidiol (CBD): A Review of the Evidence from Clinical Trials and Human Laboratory Studies.
Sholler DJ; Schoene L; Spindle TR
Curr Addict Rep; 2020 Sep; 7(3):405-412. PubMed ID: 33585159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
